Stay updated on Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Sign up to get notified when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.

Latest updates to the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPage revision changed from v3.6.4 to v3.6.5, signaling a minor update to the page's template or rendering process; no study details appear to be altered.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, reflecting a site software/template update. This does not modify study content or visible information for participants.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a small backend or documentation update; no study data or eligibility details appear to be changed.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.0 to Revision: v3.6.2, indicating a newer version of the page. This is a metadata/version update rather than a change to the study data or visible content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page adds a recruitment-closure notice and new user-help sections (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study). The header formatting changes from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision version is updated to v3.6.0.SummaryDifference0.5%

- Check78 days agoChange DetectedThe page shows a revision update from v3.5.4 to v3.5.5, indicating a minor software revision. This change does not alter the study details, eligibility criteria, or results.SummaryDifference0.1%

Stay in the know with updates to Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.